Related Experiment Videos
[Experiences with the Haemonetics cell saver]
Anasthesie, Intensivtherapie, Notfallmedizin
|August 1, 1982
Summary
The Haemonetics Cell Saver provides effective autotransfusion, recovering 53% of red blood cells (RBCs) for patient use. This method successfully removed impurities, maintaining patient homeostasis during and after surgery.
Area of Science:
- Medical devices
- Transfusion medicine
- Surgical innovation
Context:
- Autotransfusion is a critical component of modern surgical practice.
- The Haemonetics Cell Saver represents a technological advancement in blood management.
- Evaluating its efficacy in real-world clinical settings is essential.
Purpose:
- To assess the efficacy and recovery rates of the Haemonetics Cell Saver for intraoperative and intensive care unit autotransfusion.
- To determine the quality of recovered red blood cells (RBCs) and the elimination of contaminants.
- To investigate the impact of autotransfusion on patient homeostasis and coagulation parameters.
Summary:
- The Haemonetics Cell Saver was utilized in 25 patients, collecting 47.7 liters of blood loss.
- This resulted in 17.8 liters of washed RBC concentrates, achieving a 53% recovery rate of RBC loss.
- The system effectively removed activators of haemostasis and cell debris, with minimal impact on cellular and fluid homeostasis.
Impact:
- Demonstrates the clinical utility of the Haemonetics Cell Saver in improving RBC recovery during surgery.
- Highlights the potential for reduced reliance on allogeneic blood transfusions.
- Provides data on the safety and effectiveness of autotransfusion in diverse patient populations.